Tyche Industries has informed that pursuant to Regulation 29, 33, 42, 43 and 47 other applicable Clauses of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors of the Company will be held on Tuesday, 12th August, 2025 at 430 pm, at registered office of the Company to transact the following business: 1) Consider and approve the Un-Audited Financial Results of the Company for the 1st Quarter ended on 30th June 2025; and 2) Any other matters with permission of Chairman. Pursuant to the Code of Conduct to Regulate, Monitor & Report by Insider Trading of the Company, the Trading Window for dealing in securities by the Directors and Designated Persons of the Company has been closed from Tuesday, July 01, 2025 and it will open after 48 hours from the meeting of Board of Directors as scheduled above.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1665.25 |
| Dr. Reddys Lab | 1220.75 |
| Cipla | 1232.90 |
| Zydus Lifesciences | 928.85 |
| Lupin | 2311.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: